| Quarterly Financials | Mar 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
Revenue  | 216 | 278 | 260 | 293 | 331 | 402 | 300 | 296 | 300 | 303 | 334 | 328 | 342 | 282 | 314 | 293 | 326 | 384 | 318 | 338 | 319 | 407 | 432 | 421 | 545 | 438 | 450 | 516 | 547 | 596 |
| Expenses | 192 | 260 | 276 | 318 | 325 | 350 | 294 | 295 | 292 | 277 | 305 | 288 | 296 | 255 | 300 | 284 | 313 | 302 | 311 | 352 | 345 | 419 | 395 | 407 | 435 | 532 | 403 | 452 | 448 | 504 |
| EBITDA | 24 | 18 | -16 | -25 | 5 | 52 | 6 | 1 | 8 | 26 | 29 | 40 | 46 | 27 | 14 | 9 | 13 | 83 | 7 | -14 | -26 | -12 | 37 | 14 | 110 | -94 | 47 | 64 | 99 | 93 |
| Operating Profit % | -3 % | -10 % | -14 % | -22 % | -7 % | 7 % | -7 % | -10 % | -6 % | 5 % | 4 % | 9 % | 9 % | 7 % | -1 % | 2 % | -0 % | 19 % | -0 % | -7 % | -14 % | -4 % | 7 % | 2 % | 7 % | -23 % | 10 % | 11 % | 16 % | 14 % |
| Depreciation | 11 | 14 | 14 | 16 | 18 | 19 | 18 | 21 | 20 | 23 | 21 | 21 | 21 | 22 | 22 | 22 | 23 | 23 | 25 | 28 | 31 | 30 | 29 | 30 | 32 | 27 | 28 | 32 | 31 | 30 |
| Interest | 0 | 3 | 1 | 1 | 1 | 4 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 2 | 3 | 5 | 4 | 6 | 6 | 7 | 6 | 5 | 4 | 5 | 7 | 6 |
| Profit Before Tax | 13 | 2 | -31 | -43 | -14 | 29 | -14 | -22 | -13 | 0 | 7 | 18 | 24 | 3 | -9 | -16 | -11 | 58 | -21 | -47 | -61 | -47 | 2 | -22 | 73 | -126 | 15 | 27 | 62 | 58 |
| Tax | -16 | 4 | -10 | -2 | -14 | -9 | -8 | 1 | 1 | 18 | 5 | 9 | -0 | 3 | 2 | -3 | 3 | -14 | 3 | 23 | 3 | -3 | 3 | 3 | 0 | 3 | 6 | 3 | 4 | 5 |
| Net Profit | 29 | -2 | -21 | -41 | -0 | 38 | -6 | -22 | -15 | -17 | 2 | 9 | 24 | -0 | -12 | -13 | -14 | 72 | -23 | -71 | -64 | -44 | -1 | -25 | 73 | -129 | 9 | 25 | 58 | 53 |
| EPS in ₹ | 3.19 | 0.00 | -2.91 | -5.83 | -0.04 | 4.51 | -0.88 | -3.15 | -2.07 | -2.44 | 0.35 | 1.24 | 3.35 | -0.06 | -1.63 | -1.82 | -2.01 | 10.15 | -3.32 | -10.04 | -9.08 | -6.28 | -0.09 | -3.48 | 10.39 | -18.37 | 1.31 | 3.50 | 8.22 | 7.52 |
Unichem Laboratories
642.00
+16.55
(2.65%)
Q4 Quarterly Results are out. Check out the updated financials10 hours ago
Show All
Market Cap
4,520.00 Cr
EPS
-10.01
PE Ratio
32.88
Dividend Yield
0.00 %
Industry
Healthcare52 Week High
937.95
52 Week Low
501.00
PB Ratio
1.84
Debt to Equity
0.12
Sector
Pharmaceuticals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Company News
View All News
Unichem Lab Reports Significant Q4 Financial Improvement1 day ago
Unichem Lab has reported substantial year-over-year improvements in its Q4 financial results. The company's EBITDA increased to 837 million rupees from 216 million rupees in the previous year. The EBITDA margin rose to 14.25% from 4.71%. Revenue grew to 5.9 billion rupees from 4.6 billion rupees. Notably, the company turned a profit of 530 million rupees, compared to a loss of 1.2 billion rupees in the same quarter last year.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,683.60 | #1 4,03,952.00 | 35.21 | #1 49,887.20 | 12.06 | #1 9,648 | -18.99 | 40.74 | |
6,483.00 | 1,72,103.30 | 78.53 | 8,184.00 | 0.89 | 1,600 | 23.05 | 63.44 | |
1,484.20 | 1,19,866.20 | 22.74 | 26,520.70 | 14.17 | 4,155 | 30.28 | 47.86 | |
3,174.70 | 1,07,446.30 | 55.70 | 10,785.70 | 11.59 | 1,656 | 10.91 | 43.82 | |
1,230.10 | 1,02,646.40 | #1 18.15 | 28,905.40 | 12.36 | 5,578 | 21.14 | 62.40 | |
2,432.40 | 1,00,355.60 | 50.56 | 10,615.60 | 19.57 | 1,942 | -10.91 | 44.37 | |
908.60 | 91,426.40 | 19.56 | 19,831.50 | 13.82 | 3,831 | -0.19 | 56.78 | |
1,978.90 | 90,344.90 | 27.54 | 20,141.50 | #1 19.94 | 1,936 | #1 112.49 | 44.10 | |
1,197.10 | 69,527.80 | 19.71 | 29,559.20 | 17.55 | 3,169 | -10.04 | 50.83 | |
30,795.00 | 65,437.20 | 46.30 | 6,097.20 | 10.80 | 1,201 | 27.83 | 54.40 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
25.70 %
Net Income Growth
-65.13 %
Cash Flow Change
119.61 %
ROE
-64.10 %
ROCE
-74.64 %
EBITDA Margin (Avg.)
-1,588.24 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 1,169 | 1,284 | 1,527 | 3,194 | 3,150 | 3,145 | 3,126 | 3,319 | 3,193 | 3,169 |
| Fixed Assets | 416 | 403 | 491 | 578 | 810 | 870 | 884 | 990 | 1,257 | 1,196 |
| Current Assets | 564 | 600 | 749 | 2,337 | 2,038 | 1,687 | 1,377 | 1,648 | 1,589 | 1,694 |
| Capital Work in Progress | 123 | 237 | 250 | 238 | 92 | 331 | 568 | 494 | 148 | 123 |
| Investments | 35 | 14 | 14 | 901 | 926 | 550 | 392 | 264 | 2 | 1 |
| Other Assets | 595 | 630 | 772 | 1,476 | 1,321 | 1,395 | 1,282 | 1,571 | 1,787 | 1,849 |
| Total Liabilities | 1,169 | 1,284 | 1,527 | 3,194 | 3,150 | 3,145 | 3,126 | 3,319 | 3,193 | 3,169 |
| Current Liabilities | 212 | 243 | 393 | 464 | 503 | 567 | 506 | 552 | 640 | 708 |
| Non Current Liabilities | 89 | 86 | 70 | 50 | 27 | 47 | 63 | 148 | 118 | 99 |
| Total Equity | 868 | 954 | 1,064 | 2,680 | 2,620 | 2,531 | 2,557 | 2,618 | 2,435 | 2,362 |
| Reserve & Surplus | 849 | 936 | 1,045 | 2,666 | 2,606 | 2,517 | 2,543 | 2,604 | 2,421 | 2,348 |
| Share Capital | 18 | 18 | 18 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | -25 | -7 | -1 | 655 | -616 | -78 | -154 | 32 | 75 | -33 |
| Investing Activities | -52 | -85 | -128 | 1,648 | -286 | -36 | -66 | 100 | 241 | 57 |
| Operating Activities | 78 | 112 | 68 | -112 | -328 | 20 | 33 | -260 | -85 | 17 |
| Financing Activities | -51 | -33 | 59 | -881 | -2 | -62 | -121 | 191 | -81 | -106 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
| Promoter | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 70.21 % | 70.22 % | 70.22 % | 70.22 % | 70.22 % | 70.22 % | 70.22 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.83 % | 0.00 % | 0.90 % | 0.89 % | 0.94 % | 1.06 % | 0.98 % |
| DIIs | 8.49 % | 8.49 % | 8.49 % | 8.49 % | 8.49 % | 8.38 % | 7.55 % | 8.20 % | 8.16 % | 7.39 % | 10.32 % | 9.29 % | 11.27 % | 11.58 % | 11.67 % | 11.63 % | 11.32 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 30.48 % | 30.39 % | 30.50 % | 30.27 % | 29.81 % | 29.95 % | 30.17 % | 30.99 % | 30.91 % | 26.86 % | 15.80 % | 15.63 % | 15.12 % | 14.80 % | 14.58 % | 14.47 % | 14.80 % |
| Others | 10.09 % | 10.19 % | 10.08 % | 10.31 % | 10.77 % | 10.73 % | 11.34 % | 9.87 % | 9.99 % | 14.81 % | 2.84 % | 4.85 % | 2.49 % | 2.50 % | 2.60 % | 2.62 % | 2.67 % |
| No of Share Holders | 0 | 33,734 | 34,258 | 33,892 | 35,313 | 33,557 | 32,666 | 29,573 | 29,418 | 26,642 | 21,584 | 20,877 | 21,171 | 20,621 | 20,374 | 21,472 | 21,621 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 3 | 5 | 4 | 4 | 4 | 4 | 4 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 1.05 | 2.57 | 2.57 | 1.29 | 1.54 | 1.39 | 0.81 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 22 May 2025 |  Quarterly Result Announcement | NA | 22 May 2025 | 567.75 | 609.20 |
| 06 Feb 2025 | Quarterly Result Announcement | NA | 06 Feb 2025 | 676.25 | 723.80 |
| 13 Nov 2024 | Quarterly Result Announcement | NA | 13 Nov 2024 | 802.45 | 877.05 |
| 08 Aug 2024 |  Annual General Meeting | NA | 08 Aug 2024 | 537.10 | 582.45 |
| 03 Aug 2022 |  Dividend | ₹ 4.00 /share | 01 Aug 2022 | 232.65 | 295.00 |
| 26 Jul 2021 | Dividend | ₹ 4.00 /share | 22 Jul 2021 | 360.90 | 334.65 |
Announcements
Compliances-Reg.24(A)-Annual Secretarial Compliance
17 hours ago
17 hours agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication18 hours ago
18 hours agoResults For Quarter And Year Ended 20251 day ago
1 day agoBoard Meeting Outcome for Outcome1 day ago
1 day agoUSFDA Inspection Report For Pithampur API Plant9 days ago
9 days agoBoard Meeting Intimation for Consider And Approve Financial Results For Quarter And Year Ended March 31 2025May 08, 2025
May 08, 2025Intimation Of Change In Contact Details Of Registrar And Share Transfer Agent (RTA)Apr 18, 2025
Apr 18, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Apr 08, 2025Board Meeting Outcome for Outcome Of Board MeetingMar 28, 2025
Mar 28, 2025Closure of Trading WindowMar 25, 2025
Mar 25, 2025Announcement Under Regulation 30Mar 20, 2025
Mar 20, 2025USFDA Approval For CompanyS Pithampur API FacilityMar 01, 2025
Mar 01, 2025Board Meeting Outcome for Outcome Of Board MeetingMar 01, 2025
Mar 01, 2025Announcement under Regulation 30 (LODR)-Credit RatingFeb 18, 2025
Feb 18, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 07, 2025
Feb 07, 2025Integrated Filing (Financial)Feb 06, 2025
Feb 06, 2025Financial ResultsFeb 06, 2025
Feb 06, 2025Included Mr. Utkarsh Patil Chief Manufacturing Officer - Formulations As A Senior Management Personnel Under SEBI LODR Regulations With Effect From 6Th February 2025Feb 06, 2025
Feb 06, 2025Board Meeting Outcome for Unaudited Financial Results (Consolidated & Standalone) For The Quarter And Nine-Months Ended 31St December 2024Feb 06, 2025
Feb 06, 2025Announcement Under Regulation 30(LODR) - GST (Goods
&Services Tax)Jan 27, 2025
Jan 27, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Jan 24, 2025
Jan 24, 2025Board Meeting Intimation for Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2024.Jan 14, 2025
Jan 14, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2025
Jan 07, 2025Intimation By Registrar & Transfer Agent (RTA)Jan 03, 2025
Jan 03, 2025Resignation Of Senior Managerial Personnel.Dec 17, 2024
Dec 17, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2024
Nov 14, 2024Amendment In Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive InformationNov 13, 2024
Nov 13, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 13, 2024
Nov 13, 2024Board Meeting Outcome for Unaudited Financial Statements (Consolidated & Standalone) For The Second Quarter And Half Year Ended 30Th September 2024Nov 13, 2024
Nov 13, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 10, 2024
Nov 10, 2024Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended September 30, 2024.Oct 25, 2024
Oct 25, 2024Reply Letter On A Significant Increase In The Volume.Oct 23, 2024
Oct 23, 2024Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 11, 2024
Oct 11, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 04, 2024
Oct 04, 2024Board Meeting Outcome for Outcome Of Board MeetingSep 30, 2024
Sep 30, 2024Closure of Trading WindowSep 23, 2024
Sep 23, 2024Board Meeting Intimation for Integration And Consolidation Of The Generics FormulationsBusiness In The US Market.Sep 23, 2024
Sep 23, 2024Intimation Under Regulation 30 Of SEBI LODRSep 10, 2024
Sep 10, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2024
Sep 03, 2024Announcement under Regulation 30 (LODR)-Change in Registered Office AddressSep 03, 2024
Sep 03, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateAug 23, 2024
Aug 23, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 09, 2024
Aug 09, 2024Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportAug 08, 2024
Aug 08, 2024Shareholder Meeting / Postal Ballot-Outcome of AGMAug 08, 2024
Aug 08, 2024Change In Key Managerial Personnel For Determining And Disclosure Of Material EventsAug 08, 2024
Aug 08, 2024Board Meeting Outcome for Outcome Of Board MeetingAug 08, 2024
Aug 08, 2024Outcome Of Board MeetingAug 08, 2024
Aug 08, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateAug 05, 2024
Aug 05, 2024Board Meeting Intimation for Financial ResultsJul 26, 2024
Jul 26, 2024USFDA Inspection At Goa Formulation FacilityJul 15, 2024
Jul 15, 2024Technical Indicators
RSI(14)
Neutral 61.11
ATR(14)
Volatile 30.93
STOCH(9,6)
Overbought 81.12
STOCH RSI(14)
Overbought 95.70
MACD(12,26)
Bullish 9.57
ADX(14)
Weak Trend 19.95
UO(9)
Bearish 46.88
ROC(12)
Uptrend And Accelerating 12.83
WillR(14)
Overbought -19.30
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
